Goldman Sachs Group »

Halozyme Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.1M 2.8M 1.11
2022-06-30 $9.7M 11M 0.88
2022-03-31 $9.1M 10M 0.87

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Micron Technology CMN (MU)
Microsoft Corp CMN (MSFT)
Taiwan Semiconductor Manufac CMN (TSM)
Alphabet CMN (GOOGL)
Sandisk Corp CMN (SNDK)
Amazon CMN (AMZN)
Invesco Qqq Tr CMN (QQQ)
Broadcom CMN (AVGO)
Vaneck Etf Trust CMN (SMH)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Alphabet CMN (GOOG)

View all positions for Goldman Sachs Group

Top funds holding Halozyme Therapeutics

M&G
Steelhead Partners
Jpmorgan Chase & Co
Citadel Advisors
Silverback Asset Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Citigroup
Tpg Gp A
Point72 Asset Management
Balyasny Asset Management
Advent Capital Management
MacKay Shields
Calamos Advisors
Huntington Asset Advisors
Pier 88 Investment Partners

View all funds holding Halozyme Therapeutics